RCUS 8-K 2026-10-21

Arcus Biosciences, Inc. (RCUS) 8-K dated 2026-10-21 — accession 0001193125-26-427829. This URL is the filing, not the RCUS hub.

Arcus Biosciences, Inc. (RCUS) is a biotechnology company listed on US.

Arcus Biosciences, Inc. filed a 8-K on 2026-10-21. Accession 0001193125-26-427829.

Cached items: 2.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RCUS revenue for 2025-12-31 was $247.0M. Net income was -$353.0M. Revenue was down 4.3% from 2024-12-31 to 2025-12-31. RCUS currently screens at market cap $885.2M.

Not investment advice. The RCUS SEC hub lists recent forms. The stock page is the research view.